Literature DB >> 21714830

Risk factors for recurrence and death after bacteraemia: a population-based study.

U S Jensen1, J D Knudsen, S Wehberg, D B Gregson, K B Laupland.   

Abstract

Although most bacteraemic outcome studies have focused on mortality, a repeated episode(s) is another important outcome of bacteraemia. We sought to characterize patient factors and microbial species associated with recurrence and death from bacteraemia. Population-based surveillance for bacteraemia was conducted in a Canadian health region during 2000-2008. Episodes of bacteraemia were extracted and characterized. Transition intensities of both recurrence and death were estimated by separate multivariate Cox proportional hazards models. We identified 9713 patients with incident episodes of bacteraemia. Within 1 year: 892 (9.2%) had recurrent bacteraemia, 2401 (24.7%) had died without a recurrent episode and 330 (3.4%) had died after a recurrent episode. Independent risk factors for recurrence within 1 year (hazard ratio; 95% confidence interval) were: increasing Charlson comorbidity scores (score 1-2: 2.2; 1.8-2.7 and score 3+: 3.4; 2.8-4.2), origin of infection (nosocomial: 2.1; 1.8-2.6 and healthcare-associated: 2.4; 2.0-2.8), microorganism (polymicrobial: 1.5; 1.2-2.0 and fungal: 2.8; 1.9-4.2) and focus of infection (verified urogenital: 0.4; 0.3-0.6). Independent risk factors for death within 1 year included: a recurrent bacteraemic episode 3.6 (3.1-4.0), increasing age and different foci of infection. This study identifies patient groups at risk of having a recurrent episode and dying from these infections. It adds recurrent bacteraemia as an independent risk factor of death within 1 year and may help to target patients for prevention or changes in management.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21714830     DOI: 10.1111/j.1469-0691.2011.03587.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  16 in total

Review 1.  Bloodstream infections in the elderly: what is the real goal?

Authors:  Yaara Leibovici-Weissman; Noam Tau; Dafna Yahav
Journal:  Aging Clin Exp Res       Date:  2019-09-05       Impact factor: 3.636

2.  Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections.

Authors:  Joshua T Thaden; Yanhong Li; Felicia Ruffin; Stacey A Maskarinec; Jonathan M Hill-Rorie; Lisa C Wanda; Shelby D Reed; Vance G Fowler
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

Review 3.  The immune system's role in sepsis progression, resolution, and long-term outcome.

Authors:  Matthew J Delano; Peter A Ward
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

4.  Machine-learning based prediction and analysis of prognostic risk factors in patients with candidemia and bacteraemia: a 5-year analysis.

Authors:  Yali Gao; Mingsui Tang; Yaling Li; Xueli Niu; Jingyi Li; Chang Fu; Zihan Wang; Jiayi Liu; Bing Song; Hongduo Chen; Xinghua Gao; Xiuhao Guan
Journal:  PeerJ       Date:  2022-06-15       Impact factor: 3.061

5.  Classification of positive blood cultures: computer algorithms versus physicians' assessment--development of tools for surveillance of bloodstream infection prognosis using population-based laboratory databases.

Authors:  Kim O Gradel; Jenny Dahl Knudsen; Magnus Arpi; Christian Ostergaard; Henrik C Schønheyder; Mette Søgaard
Journal:  BMC Med Res Methodol       Date:  2012-09-12       Impact factor: 4.615

6.  Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona.

Authors:  Marta Riu; Pietro Chiarello; Roser Terradas; Maria Sala; Enric Garcia-Alzorriz; Xavier Castells; Santiago Grau; Francesc Cots
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

7.  Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a population-based cohort study.

Authors:  Kim O Gradel; Ulrich S Jensen; Henrik C Schønheyder; Christian Østergaard; Jenny D Knudsen; Sonja Wehberg; Mette Søgaard
Journal:  BMC Infect Dis       Date:  2017-02-06       Impact factor: 3.090

8.  Incremental cost of nosocomial bacteremia according to the focus of infection and antibiotic sensitivity of the causative microorganism in a university hospital.

Authors:  Marta Riu; Pietro Chiarello; Roser Terradas; Maria Sala; Enric Garcia-Alzorriz; Xavier Castells; Santiago Grau; Francesc Cots
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

Review 9.  Diabetes and Sepsis: Risk, Recurrence, and Ruination.

Authors:  Lynn M Frydrych; Fatemeh Fattahi; Katherine He; Peter A Ward; Matthew J Delano
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-30       Impact factor: 5.555

10.  Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study.

Authors:  Roser Terradas; Santiago Grau; Jordi Blanch; Marta Riu; Pere Saballs; Xavier Castells; Juan Pablo Horcajada; Hernando Knobel
Journal:  PLoS One       Date:  2012-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.